Quote this publication Share Print


Opinions on drugs - Posted on Apr 26 2010

Reason for request

Assessment of change of dose permitting use in children aged between 2 and 16.


Actual benefit


The clinical benefit provided by DUROGESIC in children is substantial.

Improvement in actual benefit

Commentaires sans chiffrage de l'ASMR

DUROGESIC has previously been recognised by the Transparency Committee as providing actual benefit in adults, and it provides the same benefit for children over 2.

Contact Us

Évaluation des médicaments
All our publication